Biopharma vs. CROs: who's buying more isolators?

добавлена новая статья Health

2026-04-13 11:04:31 -

Biopharma companies (Amgen, Genentech) have always used isolators — they have the money and the need. But contract research organisations (CROs) and contract manufacturing organisations (CMOs) are the fastest‑growing end‑user segment. The pharmaceutical isolator market research study shows that CROs/CMOs are growing at over 12% CAGR, because drug companies are outsourcing more...

0 Комментарии 0 Поделились 62 Просмотры 0 предпросмотр